{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:50:37Z","timestamp":1788371437197,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jiac.2020.08.019","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T09:35:02Z","timestamp":1599384902000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy, safety, and pharmacokinetics of oral valganciclovir in patients with congenital cytomegalovirus infection"],"prefix":"10.1016","volume":"27","author":[{"given":"Eisuke","family":"Suganuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nodoka","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Furuichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-7560","authenticated-orcid":false,"given":"Yoji","family":"Uejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Oh-ishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.08.019_bib1","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMra050700","article-title":"Newborn hearing screening\u2015a silent revolution","volume":"354","author":"Morton","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.08.019_bib2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jcv.2005.09.016","article-title":"Congenital cytomegalovirus (CMV) infection and hearing deficit","volume":"35","author":"Fowler","year":"2006","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jiac.2020.08.019_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013810","article-title":"Screening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: an observational study","volume":"7","author":"Yamaguchi","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiac.2020.08.019_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000118","article-title":"Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study","volume":"1","author":"Koyano","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiac.2020.08.019_bib5","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jcv.2009.09.002","article-title":"Congenital cytomegalovirus (CMV) epidemiology and awareness","volume":"46","author":"Cannon","year":"2009","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jiac.2020.08.019_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \"silent\" global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2020.08.019_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jiac.2020.08.019_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.08.019_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12887-018-1348-8","article-title":"10-year follow-up of congenital cytomegalovirus infection complicated with severe neurological findings in infancy: a case report","volume":"18","author":"Suganuma","year":"2018","journal-title":"BMC Pediatr"},{"issue":"Suppl 4","key":"10.1016\/j.jiac.2020.08.019_bib10","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","article-title":"Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system","volume":"46","author":"Oliver","year":"2009","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jiac.2020.08.019_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/528376","article-title":"Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease","volume":"197","author":"Kimberlin","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2020.08.019_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/jac\/dkp083","article-title":"Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies","volume":"63","author":"Nassetta","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2020.08.019_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bmt.1705341","article-title":"Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Ayala","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2020.08.019_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00431-006-0109-0","article-title":"Valganciclovir for treatment of congenital cytomegalovirus infection","volume":"165","author":"Schulzke","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jiac.2020.08.019_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa011759","article-title":"A\u00a0controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis","volume":"346","author":"Martin","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.08.019_bib16","series-title":"Valcyte [package insert]","year":"2013"},{"key":"10.1016\/j.jiac.2020.08.019_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/ped.12331","article-title":"New Japanese neonatal anthropometric charts for gestational age at birth","volume":"56","author":"Itabashi","year":"2014","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jiac.2020.08.019_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.braindev.2015.08.003","article-title":"Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment","volume":"38","author":"Nishida","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.jiac.2020.08.019_bib19","series-title":"Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, corrected version 2.1","year":"2017"},{"key":"10.1016\/j.jiac.2020.08.019_bib20","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1128\/JCM.43.8.4057-4063.2005","article-title":"Evaluation of the ReSSQ assay in relation to the COBAS AMPLICOR CMV MONITOR test and an in-house nested PCR method for detection of cytomegalovirus DNA","volume":"43","author":"Wirgart","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.jiac.2020.08.019_bib21","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1128\/JCM.39.12.4362-4369.2001","article-title":"Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR","volume":"39","author":"Griscelli","year":"2001","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.jiac.2020.08.019_bib22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/chromsci\/48.3.208","article-title":"A\u00a0simple, sensitive determination of ganciclovir in infant plasma by high-performance liquid chromatography with fluorescence detection","volume":"48","author":"Yoshida","year":"2010","journal-title":"J\u00a0Chromatogr Sci"},{"key":"10.1016\/j.jiac.2020.08.019_bib23","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/ijms20061388","article-title":"Efficacy of valganciclovir treatment depends on the severity of hearing dysfunction in symptomatic infants with congenital cytomegalovirus infection","volume":"20","author":"Ohyama","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiac.2020.08.019_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2012.06.001","article-title":"Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period","volume":"55","author":"del Rosal","year":"2012","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jiac.2020.08.019_bib25","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10096-009-0806-5","article-title":"Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection","volume":"28","author":"Lombardi","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2020.08.019_bib26","first-page":"208","article-title":"Pharmacokinetics, pharmacodynamics and clinical use of valganciclovir in newborns with symptomatic congenital cytomegalovirus infection","volume":"14","author":"Stronati","year":"2013","journal-title":"Curr Drug Metabol"},{"issue":"5","key":"10.1016\/j.jiac.2020.08.019_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.inf.0000261111.90075.4d","article-title":"Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants","volume":"26","author":"Galli","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jiac.2020.08.019_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/11316080-000000000-00000","article-title":"Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events","volume":"11","author":"Marshall","year":"2009","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jiac.2020.08.019_bib29","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2020.08.019_bib30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lary.28134","article-title":"Effects of ganciclovir treatment in a murine model of cytomegalovirus-induced hearing loss","volume":"130","author":"Haller","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jiac.2020.08.019_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpeds.2018.02.028","article-title":"Valganciclovir is beneficial in children with congenital cytomegalovirus and isolated hearing loss","volume":"199","author":"Pasternak","year":"2018","journal-title":"J\u00a0Pediatr"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20303123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20303123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:00:59Z","timestamp":1761159659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20303123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1341321X20303123"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.08.019","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, and pharmacokinetics of oral valganciclovir in patients with congenital cytomegalovirus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}